Upregulation of Hsa-miR-625-5p Inhibits Invasion of Acute Myeloid Leukemia Cancer Cells Through ILK/AKT Pathway
Overview
Authors
Affiliations
Objective: Acute myeloid leukemia (AML) is characterized by abnormalities of differentiation and growth of primary hematopoietic stem cells (HSCs) in the blood and bone marrow. In many studies, miR-625-5p has been shown to inhibit downstream pathways from affecting the metastasis and invasion of the integrin-linked kinase (ILK) signaling pathway. It has been proved that the expression of miR-625-5p decreases in AML cell lines. This study aimed to investigate the effect of miR-625-5p upregulation on the invasion of KG1 ell line .
Materials And Methods: In this experimental study, we investigated the impact of upregulation of miR-625-5p on invasion via the ILK/AKT pathway in the KG1 cell line. After transfection using the viral method, the cellular invasion was assessed by invasion assay and the levels of miR-625-5p genes and protein were evaluated by quantitative polymerase chain reaction (qPCR) and western blotting. Moreover, CXCR4 level was assessed by flow cytometry.
Results: The invasion significantly reduced in MiR-625-5p-transfected KG1 cells (P<0.01) that was concomitant with remarkably decreasing in the expression levels of and genes compare with the control group (P<0.01). Incontrast, and significantly increased (P<0.01, P<0.001 and P<0.01, respectively) and GSK3β did not change significantly in MiR-625-5p-transfected KG1 cells. The protein level of NF-κB decreased (P<0.01) and MMP9 increased, however it was not significant. Moreoever, the expression of CXCR4 was significantly lower (P<0.01) in comparison with the control group.
Conclusion: miR-625-5p leads to a reduction in cell invasion in the AML cell line through ILK pathway. Therefore, it could be a breakthrough in future AML-related research. However, further studies are needed to support this argument.
Zhu C, Lin L, Huang C, Wu Z Eur J Histochem. 2024; 68(4).
PMID: 39526436 PMC: 11612745. DOI: 10.4081/ejh.2024.4063.
Vlahopoulos S, Varisli L, Zoumpourlis P, Spandidos D, Zoumpourlis V Int J Oncol. 2024; 65(6).
PMID: 39513593 PMC: 11575927. DOI: 10.3892/ijo.2024.5703.
Campillo S, Gutierrez-Calabres E, Garcia-Miranda S, Griera M, Fernandez Rodriguez L, de Frutos S Cell Commun Signal. 2024; 22(1):264.
PMID: 38734696 PMC: 11088758. DOI: 10.1186/s12964-024-01646-2.
miR-758-3p/ILK signaling modulated angiogenesis by regulating VEGFA in wound healing.
Wang R, Jia J, Zhou L, Zhu X, Tang Z, Shen H Int J Med Sci. 2024; 21(1):175-187.
PMID: 38164357 PMC: 10750343. DOI: 10.7150/ijms.86733.